Screener
Perspective Therapeutics CATX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342512
FAQ
- What is Perspective Therapeutics's total equity?
- Perspective Therapeutics (CATX) reported total equity of $323.86M in Q2 2026.
- How has Perspective Therapeutics's total equity changed year-over-year?
- Perspective Therapeutics's total equity increased by 21.9% year-over-year, from $265.69M to $323.86M.
- What is the long-term trend for Perspective Therapeutics's total equity?
- Over 5 years (2020 to 2025), Perspective Therapeutics's total equity has grown at a 74.6% compound annual growth rate (CAGR), from $12.77M to $207.03M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Perspective Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude